clonazepam has been researched along with Pain, Chronic in 1 studies
Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.
Excerpt | Relevance | Reference |
---|---|---|
"Burning Mouth Syndrome (BMS) is a chronic pain condition characterized by persistent intraoral burning without related objective findings and unknown etiology that affects elderly females mostly." | 1.46 | Refractory burning mouth syndrome: clinical and paraclinical evaluation, comorbiities, treatment and outcome. ( Deligianni, CI; Ljubisavljevic, S; Mitsikostas, DD, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mitsikostas, DD | 1 |
Ljubisavljevic, S | 1 |
Deligianni, CI | 1 |
1 other study available for clonazepam and Pain, Chronic
Article | Year |
---|---|
Refractory burning mouth syndrome: clinical and paraclinical evaluation, comorbiities, treatment and outcome.
Topics: Aged; Anticonvulsants; Anxiety; Burning Mouth Syndrome; Chronic Disease; Chronic Pain; Clonazepam; C | 2017 |